Developer of artificial intelligence-based drug development data software designed to conduct patient-centric drug simulations to accelerate and de-risk drug development. The company's software combines data points from across the clinical and drug development spectrum and predicts patient response to both approved and novel therapies, allowing pharma and biotech customers to run variations of their clinical trials to improve the trial design and increase the probability of trial success, enabling healthcare industry in the discovery of new clinical opportunities and improve strategies.